Relationship Between MUC4 Variants and Metastatic Recurrence in Colorectal Cancer

References

• Yue X, Pengfei X. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10):101174. doi:10.1016/j.tranon.2021.101174
   PubMed Web of Science ®Google Scholar
• Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–732. doi:10.1038/s41575-019-0189-8
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Andrianifahanana M, Moniaux N, Batra SK. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta. 2006;1765(2):189–222. doi:10.1016/j.bbcan.2006.01.002
   PubMed Web of Science ®Google Scholar
• Zeljkovic A, Vekic J, Mihajlovic M, et al. Revealing the Role of High-Density Lipoprotein in Colorectal Cancer. Int J Mol Sci. 2021;22(7):3352. doi:10.3390/ijms22073352
   PubMed Web of Science ®Google Scholar
• Kaur S, Kumar S, Momi N, et al. Mucins in pancreatic cancer and its microenvironment. Nat Rev Gastroenterol Hepatol. 2013;10(10):607–620. doi:10.1038/nrgastro.2013.120
   PubMed Web of Science ®Google Scholar
• Pai P, Rachagani S, Dhawan P, et al. MUC4 is negatively regulated through the Wnt/beta-catenin pathway via the Notch effector Hath1 in colorectal cancer. Genes Cancer. 2016;7(5–6):154–168. doi:10.18632/genesandcancer.108
   PubMedGoogle Scholar
• Almasmoum H. The Roles of Transmembrane Mucins Located on Chromosome 7q22.1 in Colorectal Cancer. Cancer Manag Res. 2021;13:3271–3280. doi:10.2147/CMAR.S299089
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Lakshmanan I, Ponnusamy MP, et al. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells. PLoS One. 2013;8(2):e54455. doi:10.1371/journal.pone.0054455
   PubMed Web of Science ®Google Scholar
• Zhi X, Tao J, Xie K, et al. MUC4-induced nuclear translocation of beta-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer. Cancer Lett. 2014;346(1):104–113. doi:10.1016/j.canlet.2013.12.021
   PubMed Web of Science ®Google Scholar
• Hu C, Shu L, Chen C, et al. A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection. Translational Lung Cancer Res. 2022;11(1):24–42. doi:10.21037/tlcr-21-751
   PubMed Web of Science ®Google Scholar
• Shanmugam C, Jhala NC, Katkoori VR, et al. Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer. 2010;116(15):3577–3586. doi:10.1002/cncr.25095
   PubMed Web of Science ®Google Scholar
• Biemer-Hüttmann AE, Walsh MD, McGuckin MA, et al. Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J Histochem Cytochem. 1999;47(8):1039–1048. doi:10.1177/002215549904700808
   PubMed Web of Science ®Google Scholar
• Kahlenberg MS, Sullivan JM, Witmer DD, et al. Molecular prognostics in colorectal cancer. Surg Oncol. 2003;12(3):173–186. doi:10.1016/S0960-7404(03)00006-9
   PubMed Web of Science ®Google Scholar
• Ergun Y, Bal O, Dogan M, et al. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer? J Res Med Sci. 2020;25:14. doi:10.4103/jrms.JRMS_1056_18
   PubMed Web of Science ®Google Scholar
• Chandra R, Karalis JD, Liu C, et al. The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis. Cancers. 2021;13(24):6206. doi:10.3390/cancers13246206
   PubMed Web of Science ®Google Scholar
• Riihimäki M, Hemminki A, Sundquist J, et al. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765. doi:10.1038/srep29765
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Ceelen W, Ramsay RG, Narasimhan V, et al. Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases. Trends Cancer. 2020;6(3):236–246. doi:10.1016/j.trecan.2019.12.008
   PubMed Web of Science ®Google Scholar
• Franko J. Therapeutic efficacy of systemic therapy for colorectal peritoneal carcinomatosis: surgeon’s perspective. Pleura peritoneum. 2018;3(1):20180102. doi:10.1515/pp-2018-0102
   PubMed Web of Science ®Google Scholar
• Lu S, Catalano C, Huhn S, et al. Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival. PLoS One. 2019;14(5):e0216666. doi:10.1371/journal.pone.0216666
   PubMed Web of Science ®Google Scholar
• Shinji S, Yamada T, Matsuda A, et al. Recent Advances in the Treatment of Colorectal Cancer: a Review. J Nippon Med School. 2022;89(3):246–254. doi:10.1272/jnms.JNMS.2022_89-310
   PubMed Web of Science ®Google Scholar
• van der Stok EP, Spaander MCW, Grünhagen DJ, et al. Surveillance after curative treatment for colorectal cancer. Nat Rev Clin Oncol. 2017;14(5):297–315. doi:10.1038/nrclinonc.2016.199
   PubMed Web of Science ®Google Scholar
• Aiello NM, Kang Y. Context-dependent EMT programs in cancer metastasis. J Exp Med. 2019;216(5):1016–1026. doi:10.1084/jem.20181827
   PubMed Web of Science ®Google Scholar
• Miyake H, Kawai K, Nozawa H, et al. Less intensive surveillance after radical surgery for stage I-III colorectal cancer by focusing on the doubling time of recurrence. Surg Today. 2021;51(4):550–560. doi:10.1007/s00595-020-02135-y
   PubMed Web of Science ®Google Scholar
• Mo S, Ye L, Wang D, et al. Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation. JAMA oncol. 2023;9(6):770–778. doi:10.1001/jamaoncol.2023.0425
   PubMed Web of Science ®Google Scholar
• Chen G, Peng J, Xiao Q, et al. Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer. J Hematol Oncol. 2021;14(1):80. doi:10.1186/s13045-021-01089-z
   PubMed Web of Science ®Google Scholar
• Turgunov Y, Ogizbayeva A, Shakeyev K, et al. The dynamics of the lipopolysaccharide-binding protein (LBP) level in assessing the risk of adverse outcomes in operated colorectal cancer patients. Asian J Surg;2023. S1015-9584(23)01268–X. doi:10.1016/j.asjsur.2023.08.101
   Google Scholar
• Qaderi SM, Galjart B, Verhoef C, et al. Disease recurrence after colorectal cancer surgery in the modern era: a population-based study. Int J Colorectal Dis. 2021;36(11):2399–2410. doi:10.1007/s00384-021-03914-w
   PubMed Web of Science ®Google Scholar
• Yamano T, Yamauchi S, Tsukamoto K, et al. Evaluation of appropriate follow-up after curative surgery for patients with colorectal cancer using time to recurrence and survival after recurrence: a retrospective multicenter study. Oncotarget. 2018;9(39):25474–25490. doi:10.18632/oncotarget.25312
   PubMedGoogle Scholar
• Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 2004;23:77–99. doi:10.1023/A:1025815113599
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. The adenocarcinoma cell surface mucin receptor for alpha-fetoprotein: is the same receptor present on circulating monocytes and macrophages? A commentary. Tumour Biol. 2014;35(8):7397–7402. doi:10.1007/s13277-014-2183-7
   PubMedGoogle Scholar
• Ganguly K, Rauth S, Marimuthu S, et al. Unraveling mucin domains in cancer and metastasis: when protectors become predators. Cancer Metastasis Rev. 2020;39(3):647–659. doi:10.1007/s10555-020-09896-5
   PubMed Web of Science ®Google Scholar
• Dhanisha SS, Guruvayoorappan C. Pathological Implications of Mucin Signaling in Metastasis. Curr Cancer Drug Targets. 2023;23(8):585–602. doi:10.2174/1568009623666230320121332
   PubMed Web of Science ®Google Scholar
• Hwang I, Kang YN, Kim JY, et al. Prognostic significance of membrane-associated mucins 1 and 4 in gastric adenocarcinoma. Exp Ther Med. 2012;4(2):311–316. doi:10.3892/etm.2012.598
   PubMed Web of Science ®Google Scholar
• Chaturvedi P, Singh AP, Moniaux N, et al. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res. 2007;5(4):309–320. doi:10.1158/1541-7786.MCR-06-0353
   PubMed Web of Science ®Google Scholar
• Lan YT, Chang SC, Lin PC, et al. Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal Cancer. Cancers. 2021;13(8). doi:10.3390/cancers13081883
   Web of Science ®Google Scholar
• Kwon MJ, Lee JY, Kim EJ, et al. Genetic variants of MUC4 are associated with susceptibility to and mortality of colorectal cancer and exhibit synergistic effects with LDL-C levels. PLoS One. 2023;18(6):e0287768. doi:10.1371/journal.pone.0287768
   PubMed Web of Science ®Google Scholar
• Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358–363. doi:10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O
   PubMed Web of Science ®Google Scholar
• Schneider MA, Eden J, Pache B, et al. Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin. Ann Surg. 2018;268(5):845–853. doi:10.1097/SLA.0000000000002899
   PubMed Web of Science ®Google Scholar
• Roth L, Russo L, Ulugoel S, et al. Peritoneal Metastasis: current Status and Treatment Options. Cancers. 2021;14(1):60. doi:10.3390/cancers14010060
   PubMed Web of Science ®Google Scholar
• Loh CY, Chai JY, Tang TF, et al. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: signaling, Therapeutic Implications, and Challenges. Cells. 2019;8(10):1118. doi:10.3390/cells8101118
   PubMed Web of Science ®Google Scholar
• Conacci-Sorrell M, Simcha I, Ben-Yedidia T, et al. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol. 2003;163(4):847–857. doi:10.1083/jcb.200308162
   PubMed Web of Science ®Google Scholar
• Duperret EK, Ridky TW. Focal adhesion complex proteins in epidermis and squamous cell carcinoma. Cell Cycle. 2013;12(20):3272–3285. doi:10.4161/cc.26385
   PubMed Web of Science ®Google Scholar
• Chaturvedi P, Singh AP, Chakraborty S, et al. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Res. 2008;68(7):2065–2070. doi:10.1158/0008-5472.CAN-07-6041
   PubMed Web of Science ®Google Scholar
• Zhang P, Cao X, Guan M, et al. CPNE8 Promotes Gastric Cancer Metastasis by Modulating Focal Adhesion Pathway and Tumor Microenvironment. Int J Biol Sci. 2022;18(13):4932–4949. doi:10.7150/ijbs.76425
   PubMed Web of Science ®Google Scholar
• Liu L, Wu N, Wang Y, et al. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling. J Exp Clin Cancer Res. 2019;38(1):106. doi:10.1186/s13046-019-1061-y
   PubMedGoogle Scholar
• Shen L, Zhang J, Xu M, et al. DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway. Int J Biol Sci. 2022;18(10):3918–3933. doi:10.7150/ijbs.73491
   PubMed Web of Science ®Google Scholar
• Zhang M, Liu S, Chua MS, et al. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Cell Death Dis. 2019;10(8):612. doi:10.1038/s41419-019-1856-y
   PubMed Web of Science ®Google Scholar
• Liao H, Zhang L, Lu S, et al. viaKIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer PI3K/AKT/mTOR Signaling Pathway. Front Genet. 2022;13:848926. doi:10.3389/fgene.2022.848926
   PubMed Web of Science ®Google Scholar
• Jonckheere N, Skrypek N, Merlin J, et al. The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways. PLoS One. 2012;7(2):e32232. doi:10.1371/journal.pone.0032232
   PubMed Web of Science ®Google Scholar
• Rowson-Hodel AR, Wald JH, Hatakeyama J, et al. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer. Oncogene. 2018;37(2):197–207. doi:10.1038/onc.2017.327
   PubMed Web of Science ®Google Scholar
• Liu X, Li X, Wei H, et al. Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis. Front Immunol. 2023;14:1209056. doi:10.3389/fimmu.2023.1209056
   PubMed Web of Science ®Google Scholar